Preliminary Results of a Phase 1 Study of Hyperfractionated Low-Dose Radiation Therapy (RT) as a Chemotherapy Sensitizer in Combination With Gemcitabine (G) and Erlotinib (E) in Advanced Pancreatic Cancer
Year: 2013
Type: article
Study design: Clinical Trial
Authors: A.A. Konski, J. Meyer, P. Philip, A. Shields, M. Hall, M. Choi, G. Duncan, B. Adaire, E. McSpadden, S. Cohen
Institutions: Wayne State University, Fox Chase Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W1965213788
